Glycoscience, Disease, and Clinical Practice Symposium Will Be Held January 24
The NCI-funded Alliance of Glycobiologists for Detection of Cancer and Cancer Risk will host a symposium on January 24, entitled "Interfacing Glycoscience with Disease and Clinical Practice." The symposium will take place at the Natcher Conference Center on the NIH main campus in Bethesda, MD, from 8:30 a.m. to 4:30 p.m.
The symposium will highlight key developments in our understanding of how sugars are used to make complex structures critical for many life functions and provide examples of how these developments are informing areas such as disease treatment and prevention. Presentations will emphasize the many ways glycans and their binding proteins influence fundamental biological processes and how these discoveries are advancing medicine.
- Dr. John Magnani, GlycoMimetics, Inc.
- Dr. Ira Pastan, NCI
- Dr. Robert Sackstein, Harvard Medical School
- Dr. Carole Bewley, National Institute of Diabetes and Digestive and Kidney Diseases
- Dr. Ronald Schnaar, Johns Hopkins University
- Dr. Robert Haltiwanger, SUNY Stony Brook
- Dr. Richard Cummings, Emory University
- Dr. Michael Pierce, University of Georgia
- Dr. David Walt, Tufts University
Sign language interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this meeting should contact Annalisa Gnoleba at 301-594-7635 or email@example.com.